PMID: 2102278Jul 1, 1990Paper

Type of cigarettes and cancers of the upper digestive and respiratory tract

Cancer Causes & Control : CCC
C La VecchiaS Franceschi

Abstract

The relationship between type of cigarettes smoked and the risk of cancer of upper digestive and respiratory sites was investigated in a case-control study conducted in Northern Italy on 291 males with cancer of the oral cavity or pharynx, 288 with cancer of the esophagus, 162 with cancer of the larynx, and 1,272 control subjects in hospital for acute conditions unrelated to tobacco or alcohol consumption. Using a distinction based on tar-yield or the brand smoked for the longest time (less than 22 mg, low to medium tar; greater than or equal to 22 mg, high tar), the multivariate relative risks among ever-smokers were 8.5 for low/medium and 16.4 for high tar cigarettes for oral and pharyngeal neoplasms, 3.3 and 7.8 for esophageal, and 4.8 and 7.1 for laryngeal cancers. The differences according to type of cigarettes were similar in proportional terms, and hence larger in absolute terms, when analysis was restricted to current smokers only. Thus, these data provide further quantitative evidence on the importance of type of cigarette smoked on the risk of upper-digestive and respiratory tract cancers and have important public health implications.

References

Mar 1, 1979·Journal of the National Cancer Institute·E L Wynder, S D Stellman
Jan 1, 1989·Sozial- Und Präventivmedizin·F LeviP Boyle
Oct 15, 1989·International Journal of Cancer. Journal International Du Cancer·J ClavelD Hemon
Oct 15, 1989·International Journal of Cancer. Journal International Du Cancer·J D BurchA B Miller
Sep 15, 1986·International Journal of Cancer. Journal International Du Cancer·C La VecchiaS Franceschi
Jun 1, 1985·Journal of Epidemiology and Community Health·C La Vecchia
Jul 14, 1981·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·B A Bridges
Aug 15, 1984·International Journal of Cancer. Journal International Du Cancer·P VineisB Terracini
May 15, 1984·International Journal of Cancer. Journal International Du Cancer·J H LubinG Visco
Mar 1, 1981·Journal of Epidemiology and Community Health·P N Lee, L Garfinkel

❮ Previous
Next ❯

Citations

Jan 1, 1995·European Journal of Cancer. Part B, Oral Oncology·C Scully
Jul 1, 1995·European Journal of Cancer. Part B, Oral Oncology·R KulasegaramP M Speight
Sep 1, 1996·European Journal of Cancer. Part B, Oral Oncology·M S CattaruzzaP Boyle
Oct 3, 2002·Journal of the National Cancer Institute·Peter G Shields
Apr 21, 2007·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Silvano GallusCarlo La Vecchia
May 15, 2009·International Journal of Environmental Research and Public Health·Alireza Ansary-MoghaddamMark Woodward
May 29, 2004·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·G MenvielleA Leclerc
Jul 31, 2009·The Mount Sinai Journal of Medicine, New York·Alireza Ansary-MoghaddamMark Woodward
Dec 14, 2006·International Journal of Cancer. Journal International Du Cancer·Steven J ThomasRobert Maclennan
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C La VecchiaM Smans
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P Boffetta
Aug 22, 2006·Oral Oncology·Cristina BosettiCarlo La Vecchia
Jun 20, 2003·Cell Proliferation·Katrien VermeulenDirk R Van Bockstaele

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
P Vineis
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
H Sancho-Garnier, S Theobald
© 2021 Meta ULC. All rights reserved